Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 810 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 86.53 USD | -0.51% | +8.05% | +15.37% | +121.30% | 12.19 B USD | ||
| 841 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 60.45 USD | +0.17% | +4.75% | +5.30% | +3.60% | 11.68 B USD | ||
| 858 |  ABVX Abivax SA - American Depositary Shares | 141.00 USD | -0.82% | +3.14% | +39.05% | +1678.06% | 11.07 B USD | ||
| 865 |  TECH Bio-Techne Corp - Common Stock | 70.54 USD | -0.10% | -0.30% | +32.00% | +33.32% | 11.04 B USD | ||
| 878 |  KRYS Krystal Biotech, Inc. - Common Stock | 372.50 USD | +1.06% | +1.13% | +21.34% | +99.06% | 10.98 B USD | ||
| 888 |  CYTK Cytokinetics, Incorporated - Common Stock | 85.06 USD | -0.58% | +0.39% | +23.99% | +46.40% | 10.58 B USD | ||
| 913 |  CORT Corcept Therapeutics Incorporated - Common Stock | 94.13 USD | +0.10% | +8.01% | +27.19% | +28.29% | 10.11 B USD | ||
| 930 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.87 USD | -0.31% | +3.05% | +58.75% | +101.13% | 9.78 B USD | ||
| 934 |  NUVL Nuvalent, Inc. - Class A Common Stock | 123.78 USD | +0.01% | +0.15% | +0.79% | +30.36% | 9.78 B USD | ||
| 939 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 79.93 USD | -2.01% | +4.29% | +11.04% | +19.66% | 9.48 B USD | ||
| 971 |  IBRX ImmunityBio, Inc. - Common Stock | 9.05 USD | +3.31% | +2.14% | +23.97% | +229.09% | 9.48 B USD | ||
| 974 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 138.45 USD | -1.70% | +11.57% | +40.56% | +84.28% | 8.90 B USD | ||
| 977 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 330.19 USD | +1.93% | -0.26% | +27.98% | +592.66% | 9.21 B USD | ||
| 988 |  TGTX TG Therapeutics, Inc. - Common Stock | 57.96 USD | -0.17% | +6.50% | +36.41% | +61.04% | 8.87 B USD | ||
| 995 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.51 USD | -0.02% | +119.76% | +147.29% | +103.19% | 8.81 B USD | ||
| 997 |  PCVX Vaxcyte, Inc. - Common Stock | 59.50 USD | -1.93% | +3.57% | +26.78% | +40.66% | 8.59 B USD | ||
| 1015 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 66.40 USD | -1.32% | +5.58% | +33.66% | +67.47% | 8.30 B USD | ||
| 1025 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.65 USD | +0.08% | +0.69% | +59.72% | +149.39% | 8.27 B USD | ||
| 1027 |  IMVT Immunovant, Inc. - Common Stock | 39.78 USD | -0.77% | +2.61% | +26.61% | +107.08% | 8.17 B USD | ||
| 1029 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 94.21 USD | -0.02% | +7.22% | +29.11% | +294.02% | 8.18 B USD |
Nouvelles Biotechnology Stocks
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Nurix Therapeutics : les résultats sous l’œil de l’accord avec Roche
L’action Edgewise Therapeutics atteint un sommet historique à 43,96 $
Stifel abaisse la note de Crinetics à Conserver après l’acquisition par Vertex
Gainers Biotechnology Stocks
 APLMW Apollomics Inc. - Warrant | 0.0184 | +53.33% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 PRME Prime Medicine, Inc. - Common Stock | 4.68 | +17.29% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.17 | +13.21% |
 ANVS Annovis Bio, Inc. Common Stock | 2.16 | +11.92% |
 BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.27 | +11.82% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
 ELOX Eloxx Pharmaceuticals, Inc. | 12.01 | +9.68% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0133 | -20.83% |
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.31 | -16.61% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 PHGE BiomX Inc. COmmon Stock | 0.26 | -13.33% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1053 | -11.21% |
 ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0204 | -10.92% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.44 | -10.20% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.34 | -9.83% |